T-CELL LYMPHOBLASTIC LYMPHOMA
Clinical trials for T-CELL LYMPHOBLASTIC LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new T-CELL LYMPHOBLASTIC LYMPHOMA trials appear
Sign up with your email to follow new studies for T-CELL LYMPHOBLASTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New trial aims to boost survival in kids with rare lymphoma
Disease control Recruiting nowThis study compares two different ways of giving the chemotherapy drug methotrexate to children and teens newly diagnosed with T-cell lymphoblastic lymphoma, a rare cancer. The goal is to see which approach leads to better event-free survival. About 200 participants will be rando…
Matched conditions: T-CELL LYMPHOBLASTIC LYMPHOMA
Phase: PHASE3 • Sponsor: Children's Cancer Group, China • Aim: Disease control
Last updated May 01, 2026 15:59 UTC
-
Promising drug cocktail targets tough blood cancers in kids
Disease control Recruiting nowThis study tests whether a combination of three drugs (calaspargase pegol-mknl, decitabine, and venetoclax) can help control relapsed or treatment-resistant T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LLy) in patients aged 1 month to 21 years.…
Matched conditions: T-CELL LYMPHOBLASTIC LYMPHOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 01, 2026 15:58 UTC